Photo taken from American Association for Cancer Research/LinkedIn
Apr 28, 2024, 14:39
Harpreet Singh: Join us for what promises to be an exciting and informative workshop on the approach to resectable, early stage tumors
Harpreet Singh, Division Direction at FDA Oncology shared a post by American Association for Cancer Research on LinkedIn, adding:
“Join us for what promises to be an exciting and informative workshop on the approach to resectable, early stage tumors.”
Quoting American Association for Cancer Research’s post:
“How Much is Enough? Trial designs for treatment regimens with multiple phases, AACR Past President Elizabeth M. Jaffee joins FDA’s Harpreet Singh to chair this AACR-FDA workshop. Join us May 9 in Bethesda, MD, or on livestream. Learn more.”
Source: Harpreet Singh/LinkedIn and American Association for Cancer Research/LinkedIn